English
SpanishTrusted Resources: People & Places
Healthcare providers, researchers, and advocates
The Medical University of South Carolina Health Graves’ Eye Disease Clinic
171 Ashley AvenueCharleston, South Carolina, United States
Phone Web
The Medical University of South Carolina Health Graves’ Eye Disease Clinic provides comprehensive care to patients suffering with Graves’ eye disease by providing the latest medical and surgical treatments and by organizing care among a single team.
We provide a seamless experience for patients and strive for the best possible outcomes. Our team includes specialist physicians from Storm Eye Institute (oculoplastics, neuro-ophthalmology, and strabismus surgery), the Division of Endocrinology, and the MUSC Health Sinus Center (rhinology/sinus surgery). Each of these physicians has a dedicated interest in Graves’ eye disease and extensive experience managing the needs of this special patient population.
Many of our patients travel a great distance and will ultimately need to see several different specialists during the course of their treatment. Our clinic staff will help coordinate various appointments and facilitate communication between all of your different physicians.
myBinderRelated Content
-
Treatment Options for Thyroid Eye or Graves’ Disease at Ohio Statehttps://www.youtube.com/watch?v=2vcbs9hu...
-
Michael K. Yoon, MDDr. Michael Yoon is a member of the Mass...
-
Mortality in Graves’ Orbitopathy is Increased and Influenced By Gender, Age and Pre-Existing Morbidity: A Nati...Introduction: It is unclear whether the...
-
Dealing With Thyroid Eye Disease: Patient and Physician PerspectivesJoin us for a webinar hosted by the Grav...
-
Genetic Associations of the Thyroid Stimulating Hormone Receptor Gene With Graves’ Diseases and Graves’ ...Graves' disease (GD) is a common thyroid...
-
Keck Medicine of University of Southern CaliforniaAt Keck Medicine of University of Southe...
-
Comparison of Two Different Regimens of Intravenous Methylprednisolone for Patients With Moderate to Severe and Acti...The intravenous methylprednisolone (iv M...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
